Contact
searchSearch
HMP Global

Advances in Inflammatory Bowel Disease Network

Featured

Research Review
Guselkumab Improves Fistula Remission in Perianal Crohn’s Disease in Phase 3 Trial
05/08/2026
Jessica Garlewicz
FUZION is the first and only randomized, controlled trial to show efficacy of an IL-23p19 antagonist in perianal fistulizing Crohn’s disease and the first trial of any therapy for perianal Crohn's disease since 1999.
FUZION is the first and only randomized, controlled trial to show efficacy of an IL-23p19 antagonist in perianal fistulizing Crohn’s disease and the first trial of any therapy for perianal Crohn's disease since 1999.
FUZION is the first and only...
05/08/2026
Advances in Inflammatory Bowel Disease Network
Stephen Hanauer
Conference Coverage
Stephen Hanauer, MD, on Themes in IBD at DDW
05/07/2026
Stephen B. Hanauer, MD
Dr Hanauer reviews the key themes that were discussed in sessions on inflammatory bowel diseases at Digestive Diseases Week 2026, including prevention, early treatment, and combination therapy.
Dr Hanauer reviews the key themes that were discussed in sessions on inflammatory bowel diseases at Digestive Diseases Week 2026, including prevention, early treatment, and combination therapy.
Dr Hanauer reviews the key...
05/07/2026
Advances in Inflammatory Bowel Disease Network
Research Highlights
Combined Ultrasound and Calprotectin at 3 Months Predict Postoperative Recurrence in Crohn’s Disease
05/07/2026
Jessica Garlewicz
High specificity and positive predictive value suggest that patients meeting both thresholds are at high risk for early recurrence and may need closer monitoring.
High specificity and positive predictive value suggest that patients meeting both thresholds are at high risk for early recurrence and may need closer monitoring.
High specificity and positive...
05/07/2026
Advances in Inflammatory Bowel Disease Network
Research Summary
Long-Term Safety of Mirikizumab Remains Stable Across UC and Crohn’s Disease
05/07/2026
Jessica Garlewicz
Sustained therapy did not appear to introduce cumulative risk, supporting continued use in patients requiring maintenance treatment.
Sustained therapy did not appear to introduce cumulative risk, supporting continued use in patients requiring maintenance treatment.
Sustained therapy did not appear...
05/07/2026
Advances in Inflammatory Bowel Disease Network
RESEARCH INSIGHTS
Early Endoscopic and Histologic Response With Guselkumab Predicts Long-Term Remission in UC
05/06/2026
Jessica Garlewicz
At week 0, 66.8% to 77.3% of patients who achieved these endpoints went on to achieve corticosteroid-free clinical remission at week 92.
At week 0, 66.8% to 77.3% of patients who achieved these endpoints went on to achieve corticosteroid-free clinical remission at week 92.
At week 0, 66.8% to 77.3% of...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Research Highlights
GLP-1 Receptor Agonists Linked to Reduced Steroid Use and Escalation in IBD
05/06/2026
Jessica Garlewicz
In ulcerative colitis, GLP-1 RA use was associated with reductions in the use of corticosteroids and acute care utilization.
In ulcerative colitis, GLP-1 RA use was associated with reductions in the use of corticosteroids and acute care utilization.
In ulcerative colitis, GLP-1 RA...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Research Review
Combined Ultrasound and Calprotectin at 3 Months Predict Postoperative Recurrence in Crohn’s Disease
05/06/2026
Jessica Garlewicz
The study findings support a noninvasive approach to risk stratification before routine colonoscopic evaluation.
The study findings support a noninvasive approach to risk stratification before routine colonoscopic evaluation.
The study findings support a...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Research Review
Mirikizumab Shows Progressive Histologic Improvement in Ulcerative Colitis, With Strong Rectal Response
05/06/2026
Jessica Garlewicz
The study uniquely focused on patients with baseline bowel urgency, integrating symptom burden with objective mucosal healing endpoints.
The study uniquely focused on patients with baseline bowel urgency, integrating symptom burden with objective mucosal healing endpoints.
The study uniquely focused on...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Research Highlights
Active IBD and Steroid Use Linked to Higher RSV Risk
05/06/2026
Jessica Garlewicz
Among vaccinated patients with active IBD, RSV infection rates were no longer significantly different compared with those with nonactive disease.
Among vaccinated patients with active IBD, RSV infection rates were no longer significantly different compared with those with nonactive disease.
Among vaccinated patients with...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Research Highlights
Early Endoscopic and Histologic Response With Guselkumab Predicts Long-Term Remission in UC
05/06/2026
Jessica Garlewicz
Endoscopic and histologic improvements early in treatment appear to serve as reliable indicators of sustained remission without corticosteroids.
Endoscopic and histologic improvements early in treatment appear to serve as reliable indicators of sustained remission without corticosteroids.
Endoscopic and histologic...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Jean-Frederic Colombel
Expert Insights
Jean-Frederic Colombel, MD, on Disease Clearance With Mirikizumab in Ulcerative Colitis
05/06/2026
Jean-Frederic Colombel
Dr Colombel discusses his presentation at DDW 2026 on a post-doc analysis of the long-term outcomes of the LUCENT trial of mirikizumab, which showed that the IL-23p19 inhibitor achieved and maintained disease clearance for up to 4 years among...
Dr Colombel discusses his presentation at DDW 2026 on a post-doc analysis of the long-term outcomes of the LUCENT trial of mirikizumab, which showed that the IL-23p19 inhibitor achieved and maintained disease clearance for up to 4 years among...
Dr Colombel discusses his...
05/06/2026
Advances in Inflammatory Bowel Disease Network

Interactive Features

Quiz
Terminal Ileal Resection and CRC Risk
08/07/2025
Rebecca Mashaw
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in...
08/07/2025
Gastroenterology
Quiz
Does Hormone Replacement Therapy Affect IBD?
07/18/2025
Can hormone replacement therapy help or harm disease activity among women with IBD? Our quiz will show the answer!
Can hormone replacement therapy help or harm disease activity among women with IBD? Our quiz will show the answer!
Can hormone replacement therapy...
07/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Can Perspiration Reveal IBD Biomarkers?
07/18/2025
Can a wearable sensor help monitor disease activity in IBD--via sweat? Take our quiz to get the answer.
Can a wearable sensor help monitor disease activity in IBD--via sweat? Take our quiz to get the answer.
Can a wearable sensor help...
07/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Making EHRs Work
07/01/2025
Rebecca Mashaw
Which of the following factors did clinicians say in a recent study is particularly important for EHR functionality in the context of IBD?
Which of the following factors did clinicians say in a recent study is particularly important for EHR functionality in the context of IBD?
Which of the following factors...
07/01/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Do EHRs Help or Hinder in IBD Care?
07/01/2025
Rebecca Mashaw
According to a recent survey of clinicians who care for patients with inflammatory bowel disease, what percentage reported that their EHR system does not enhance patient care in IBD?
According to a recent survey of clinicians who care for patients with inflammatory bowel disease, what percentage reported that their EHR system does not enhance patient care in IBD?
According to a recent survey of...
07/01/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Advanced Combination Treatment for Refractory IBD
07/01/2025
Rebecca Mashaw
A multicenter Canadian study to evaluate advanced combination treatment (ACT) in patients with refractory inflammatory bowel disease (IBD) arrived at which of the following conclusions?
A multicenter Canadian study to evaluate advanced combination treatment (ACT) in patients with refractory inflammatory bowel disease (IBD) arrived at which of the following conclusions?
A multicenter Canadian study to...
07/01/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Hormone Replacement Impact on IBD
05/22/2025
Rebecca Mashaw
Does hormone replacement therapy have any effect on treatment for IBD among postmenopausal women? Take our quiz to find out!
Does hormone replacement therapy have any effect on treatment for IBD among postmenopausal women? Take our quiz to find out!
Does hormone replacement therapy...
05/22/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Upper GI Crohn's Disease
03/18/2025
Rebecca Mashaw
How much do you know about upper GI Crohn's disease? Take our quiz to check your knowledge!
How much do you know about upper GI Crohn's disease? Take our quiz to check your knowledge!
How much do you know about upper...
03/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Preoperative Nutrition for Crohn’s Disease Patients
03/18/2025
Rebecca Mashaw
What is one benefit of preoperative exclusive enteral nutrition for Crohn’s disease patients? Take our quiz to find out if you know the answer!
What is one benefit of preoperative exclusive enteral nutrition for Crohn’s disease patients? Take our quiz to find out if you know the answer!
What is one benefit of...
03/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Risk Factors for Surgery in Crohn’s Disease
02/26/2025
Rebecca Mashaw
Estimates vary but indicate that half or more of patients with Crohn's disease will require surgery at some point in their disease course. Do you know which factors place your patients at high risk for surgery? Take our quiz to find out!
Estimates vary but indicate that half or more of patients with Crohn's disease will require surgery at some point in their disease course. Do you know which factors place your patients at high risk for surgery? Take our quiz to find out!
Estimates vary but indicate that...
02/26/2025
Advances in Inflammatory Bowel Disease Network

Expert Insights

Stephen Hanauer
Conference Coverage
Stephen Hanauer, MD, on Themes in IBD at DDW
05/07/2026
Stephen B. Hanauer, MD
Dr Hanauer reviews the key themes that were discussed in sessions on inflammatory bowel diseases at Digestive Diseases Week 2026, including prevention, early treatment, and combination therapy.
Dr Hanauer reviews the key themes that were discussed in sessions on inflammatory bowel diseases at Digestive Diseases Week 2026, including prevention, early treatment, and combination therapy.
Dr Hanauer reviews the key...
05/07/2026
Advances in Inflammatory Bowel Disease Network
Jean-Frederic Colombel
Expert Insights
Jean-Frederic Colombel, MD, on Disease Clearance With Mirikizumab in Ulcerative Colitis
05/06/2026
Jean-Frederic Colombel
Dr Colombel discusses his presentation at DDW 2026 on a post-doc analysis of the long-term outcomes of the LUCENT trial of mirikizumab, which showed that the IL-23p19 inhibitor achieved and maintained disease clearance for up to 4 years among...
Dr Colombel discusses his presentation at DDW 2026 on a post-doc analysis of the long-term outcomes of the LUCENT trial of mirikizumab, which showed that the IL-23p19 inhibitor achieved and maintained disease clearance for up to 4 years among...
Dr Colombel discusses his...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Ed Barnes
Conference Coverage
Edward Barnes, MD on the VIVID Trials of Mirikizumab in Bio-Exposed Patients With Crohn's Disease
05/06/2026
Edward L. Barnes, MD
Dr Barnes reviewed his presentation of results from the VIVID 1 and VIVID 2 trials of mirkizumab in patients with Crohn's disease with exposure to anti-TNF therapy, which found that 65% of those in endoscopic response at week 52 maintained...
Dr Barnes reviewed his presentation of results from the VIVID 1 and VIVID 2 trials of mirkizumab in patients with Crohn's disease with exposure to anti-TNF therapy, which found that 65% of those in endoscopic response at week 52 maintained...
Dr Barnes reviewed his...
05/06/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Colleen Kelly, MD, on Obesity and IBD
04/20/2026
Raymond Cross, MD; Colleen Kelly, MD
Host Raymond Cross, MD, calls on Dr Colleen Kelly to discuss the increasing prevalence of obesity among patients with IBD, how obesity can complicate Crohn's disease and ulcerative colitis, and the role of GLP-1 RAs and bariatric surgery in...
Host Raymond Cross, MD, calls on Dr Colleen Kelly to discuss the increasing prevalence of obesity among patients with IBD, how obesity can complicate Crohn's disease and ulcerative colitis, and the role of GLP-1 RAs and bariatric surgery in...
Host Raymond Cross, MD, calls on...
04/20/2026
Advances in Inflammatory Bowel Disease Network
From the AIBD Open Air Studio
Becoming an AIBD Ambassador
04/14/2026
Tenzin Choden, MD; Cindy Law, MD; Amelia Kellar, MD; Payal Kadakiya, PharmD
AIBD Ambassadors Tenzin Choden, Amelia Kellar, Cindy Law, and Payal Kakadiya share their experiences as they have assisted with program planning, poster abstract and content review, and mentored research presentations as they build their...
AIBD Ambassadors Tenzin Choden, Amelia Kellar, Cindy Law, and Payal Kakadiya share their experiences as they have assisted with program planning, poster abstract and content review, and mentored research presentations as they build their...
AIBD Ambassadors Tenzin Choden,...
04/14/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Jared Magee, MD, on Men's Health in IBD
04/07/2026
Raymond Cross, MD; Jared Magee, MD
Drs Raymond Cross and Jared Magee discuss some of the special concerns that affect men with inflammatory bowel disease, from cardiac concerns to sexual dysfunction and assessing for anal cancer.
Drs Raymond Cross and Jared Magee discuss some of the special concerns that affect men with inflammatory bowel disease, from cardiac concerns to sexual dysfunction and assessing for anal cancer.
Drs Raymond Cross and Jared...
04/07/2026
Advances in Inflammatory Bowel Disease Network
From the AIBD Open Air Studio
AIBD: Past, Present, and Future
03/31/2026
Millie D. Long, MD, MPH; Miguel D. Regueiro, MD; Corey A. Siegel, MD, MS
Drs Millie Long, Miguel Regueiro, and Corey Siegel, cochairs of the Advances in IBD annual meeting, discuss the past and present of the conference and look forward to the 25th anniversary of AIBD in December 2026.
Drs Millie Long, Miguel Regueiro, and Corey Siegel, cochairs of the Advances in IBD annual meeting, discuss the past and present of the conference and look forward to the 25th anniversary of AIBD in December 2026.
Drs Millie Long, Miguel...
03/31/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: The Best of ECCO 2026
03/25/2026
Raymond Cross, MD; Sara Horst, MD; Jordan Axelrad, MD
Host Raymond Cross, MD, is joined by Drs Sara Horst and Jordan Axelrad to review the findings of their picks for the best presentations from the European Crohn's and Colitis Organization meeting held earlier this year.
Host Raymond Cross, MD, is joined by Drs Sara Horst and Jordan Axelrad to review the findings of their picks for the best presentations from the European Crohn's and Colitis Organization meeting held earlier this year.
Host Raymond Cross, MD, is...
03/25/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Shirley Cohen-Mekelburg, MD on Self-Care for IBD Patients
03/17/2026
Shirley Cohen-Mekelburg; Raymond Cross, MD
Host Raymond Cross, MD, calls on Dr Shirley Mekelburg-Cohen to discuss the importance of self-care among patients with IBD, what self-care consists of, and how to help patients learn to partner with their clinicians in controlling their...
Host Raymond Cross, MD, calls on Dr Shirley Mekelburg-Cohen to discuss the importance of self-care among patients with IBD, what self-care consists of, and how to help patients learn to partner with their clinicians in controlling their...
Host Raymond Cross, MD, calls on...
03/17/2026
Advances in Inflammatory Bowel Disease Network
New IBD Logo
Expert Insights
IBD Drive Time: James Lewis, MD, on Dysplasia Surveillance in IBD
02/23/2026
Raymond Cross, MD; James D. Lewis, MD
Dr James Lewis from the University of Pennsylvania and host Dr Raymond Cross discuss the risk of colon cancer among patients with inflammatory bowel disease, the importance of appropriate surveillance, and special considerations for choosing...
Dr James Lewis from the University of Pennsylvania and host Dr Raymond Cross discuss the risk of colon cancer among patients with inflammatory bowel disease, the importance of appropriate surveillance, and special considerations for choosing...
Dr James Lewis from the...
02/23/2026
Advances in Inflammatory Bowel Disease Network

Conference Coverage

Research Review
Guselkumab Improves Fistula Remission in Perianal Crohn’s Disease in Phase 3 Trial
05/08/2026
Jessica Garlewicz
FUZION is the first and only randomized, controlled trial to show efficacy of an IL-23p19 antagonist in perianal fistulizing Crohn’s disease and the first trial of any therapy for perianal Crohn's disease since 1999.
FUZION is the first and only randomized, controlled trial to show efficacy of an IL-23p19 antagonist in perianal fistulizing Crohn’s disease and the first trial of any therapy for perianal Crohn's disease since 1999.
FUZION is the first and only...
05/08/2026
Advances in Inflammatory Bowel Disease Network
Research Review
Mirikizumab Shows Progressive Histologic Improvement in Ulcerative Colitis, With Strong Rectal Response
05/06/2026
Jessica Garlewicz
The study uniquely focused on patients with baseline bowel urgency, integrating symptom burden with objective mucosal healing endpoints.
The study uniquely focused on patients with baseline bowel urgency, integrating symptom burden with objective mucosal healing endpoints.
The study uniquely focused on...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Research Highlights
Active IBD and Steroid Use Linked to Higher RSV Risk
05/06/2026
Jessica Garlewicz
Among vaccinated patients with active IBD, RSV infection rates were no longer significantly different compared with those with nonactive disease.
Among vaccinated patients with active IBD, RSV infection rates were no longer significantly different compared with those with nonactive disease.
Among vaccinated patients with...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Research Highlights
Early Endoscopic and Histologic Response With Guselkumab Predicts Long-Term Remission in UC
05/06/2026
Jessica Garlewicz
Endoscopic and histologic improvements early in treatment appear to serve as reliable indicators of sustained remission without corticosteroids.
Endoscopic and histologic improvements early in treatment appear to serve as reliable indicators of sustained remission without corticosteroids.
Endoscopic and histologic...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Research Review
Combined Ultrasound and Calprotectin at 3 Months Predict Postoperative Recurrence in Crohn’s Disease
05/06/2026
Jessica Garlewicz
The study findings support a noninvasive approach to risk stratification before routine colonoscopic evaluation.
The study findings support a noninvasive approach to risk stratification before routine colonoscopic evaluation.
The study findings support a...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Best of 2025
From the AIBD Open Air Studio
Best of 2025 in IBD: Expert Roundtable from Advances in IBD
12/18/2025
Marla C. Dubinsky, MD; Parambir Dulai, MD; Bruce E. Sands, MD, MS
Drs Marla Dubinsky, Bruce Sands, and Parambir Dulai inaugurated the Open Air Studio at the Advances in IBD 2025 annual meeting with a review of the best research and most promising advances in the treatment of inflammatory bowel disease...
Drs Marla Dubinsky, Bruce Sands, and Parambir Dulai inaugurated the Open Air Studio at the Advances in IBD 2025 annual meeting with a review of the best research and most promising advances in the treatment of inflammatory bowel disease...
Drs Marla Dubinsky, Bruce Sands,...
12/18/2025
Advances in Inflammatory Bowel Disease Network
Phillip Fleshner
Conference Coverage
Phillip Fleshner, MD, on the Top Things Surgeons Want Gastroenterologists to Know
12/18/2025
Rebecca Mashaw
In his address to the Advances in IBD annual meeting, Dr Phillip Fleshner stressed the importance of early involvement of the surgeon in collaborative patient care and that the need for surgery should not be viewed as a failure of medical...
In his address to the Advances in IBD annual meeting, Dr Phillip Fleshner stressed the importance of early involvement of the surgeon in collaborative patient care and that the need for surgery should not be viewed as a failure of medical...
In his address to the Advances...
12/18/2025
Advances in Inflammatory Bowel Disease Network
Ray Cross
Conference Coverage
Raymond Cross, MD, on Risk Stratification and Individualized Treatment Selection in Evolving IBD Management
12/17/2025
Jessica Garlewicz
Dr Raymond Cross emphasized the importance of identifying risk early and aligning therapy with both clinical severity and patient-specific needs as IBD moves toward precision medicine.
Dr Raymond Cross emphasized the importance of identifying risk early and aligning therapy with both clinical severity and patient-specific needs as IBD moves toward precision medicine.
Dr Raymond Cross emphasized the...
12/17/2025
Advances in Inflammatory Bowel Disease Network
Millie Long
Conference Coverage
Millie Long, MD, on Understanding Infection Risk in IBD
12/17/2025
Jessica Garlewicz
Steroid reduction, risk stratification, and preventive strategies remain central, Dr Long said at the Advances in IBD annual meeting.
Steroid reduction, risk stratification, and preventive strategies remain central, Dr Long said at the Advances in IBD annual meeting.
Steroid reduction, risk...
12/17/2025
Advances in Inflammatory Bowel Disease Network
Amy Stewart
From the AIBD Open Air Studio
Amy Stewart, NP, on Advances in Subcutaneous IBD Therapy
12/17/2025
Amy Stewart, NP
Amy Stewart, NP, the results of a post-hoc analysis of data from the LIBERTY study in Crohn's disease for Zymfentra, a subcutaneous formulation of infliximab, and how it and other subcutaneous options provide important options for patients...
Amy Stewart, NP, the results of a post-hoc analysis of data from the LIBERTY study in Crohn's disease for Zymfentra, a subcutaneous formulation of infliximab, and how it and other subcutaneous options provide important options for patients...
Amy Stewart, NP, the results of...
12/17/2025
Advances in Inflammatory Bowel Disease Network

Latest News

Research Highlights
Combined Ultrasound and Calprotectin at 3 Months Predict Postoperative Recurrence in Crohn’s Disease
05/07/2026
Jessica Garlewicz
High specificity and positive predictive value suggest that patients meeting both thresholds are at high risk for early recurrence and may need closer monitoring.
High specificity and positive predictive value suggest that patients meeting both thresholds are at high risk for early recurrence and may need closer monitoring.
High specificity and positive...
05/07/2026
Advances in Inflammatory Bowel Disease Network
RESEARCH INSIGHTS
Early Endoscopic and Histologic Response With Guselkumab Predicts Long-Term Remission in UC
05/06/2026
Jessica Garlewicz
At week 0, 66.8% to 77.3% of patients who achieved these endpoints went on to achieve corticosteroid-free clinical remission at week 92.
At week 0, 66.8% to 77.3% of patients who achieved these endpoints went on to achieve corticosteroid-free clinical remission at week 92.
At week 0, 66.8% to 77.3% of...
05/06/2026
Advances in Inflammatory Bowel Disease Network
News
Oral Icotrokinra Demonstrates Efficacy in Ulcerative Colitis Regardless of Prior Advanced Therapy Exposure
05/05/2026
Jessica Garlewicz
While response rates were generally higher in patients without prior advanced therapy failure, meaningful improvements were still seen in those with treatment-resistant disease.
While response rates were generally higher in patients without prior advanced therapy failure, meaningful improvements were still seen in those with treatment-resistant disease.
While response rates were...
05/05/2026
Advances in Inflammatory Bowel Disease Network
Research Review
Early “Top-Down” Therapy Reduces Long-Term Complications in Crohn’s Disease
05/05/2026
Jessica Garlewicz
Disease progression and hospitalizations were more common in the step-up group, with higher rates of stricturing and penetrating complications.
Disease progression and hospitalizations were more common in the step-up group, with higher rates of stricturing and penetrating complications.
Disease progression and...
05/05/2026
Advances in Inflammatory Bowel Disease Network
Research Review
Upper GI Crohn’s Disease Remains Underrecognized, Lacks Standardized Guidance
04/02/2026
Jessica Garlewicz
A recent review noted a lack of consistent diagnostic definitions across modalities, complicating clinical interpretation and research comparisons.
A recent review noted a lack of consistent diagnostic definitions across modalities, complicating clinical interpretation and research comparisons.
A recent review noted a lack of...
04/02/2026
Advances in Inflammatory Bowel Disease Network
Research Summary
Advanced Therapy May Reduce Antibiotic Dependence in Chronic Pouchitis After IPAA
03/18/2026
Jessica Garlewicz
These findings support considering immune-mediated therapy in selected patients although more research is needed to identify the patients likely to benefit most from advanced therapy.
These findings support considering immune-mediated therapy in selected patients although more research is needed to identify the patients likely to benefit most from advanced therapy.
These findings support...
03/18/2026
Advances in Inflammatory Bowel Disease Network
Research Review
New Meta-Analysis Highlights Burden of MASLD Among IBD Patients
02/03/2026
Rebecca Mashaw
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from...
02/03/2026
Gastroenterology
News
Medicare Will Cover GLP-1s for Obesity Under Deal with Pharma
11/06/2025
Rebecca Mashaw
Administration officials said the new lower prices also will be provided for Medicaid programs, with prices and timing decided state by state as they opt in.
Administration officials said the new lower prices also will be provided for Medicaid programs, with prices and timing decided state by state as they opt in.
Administration officials said...
11/06/2025
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Updated Indication for Upadacitinib in IBD
10/14/2025
Rebecca Mashaw
The new indication allows for upadacitinib therapy among patients who have received any approved systemic therapy for IBD “in the event TNF blockers are clinically inadvisable."
The new indication allows for upadacitinib therapy among patients who have received any approved systemic therapy for IBD “in the event TNF blockers are clinically inadvisable."
The new indication allows for...
10/14/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Concomitant Medications Do Not Alter Efficacy of Advanced Therapies in Ulcerative Colitis, Study Finds
09/18/2025
Jessica Garlewicz
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that...
09/18/2025
Advances in Inflammatory Bowel Disease Network

Latest Podcasts

IBD Drive time logo
Expert Insights
IBD Drive Time: Colleen Kelly, MD, on Obesity and IBD
04/20/2026
Raymond Cross, MD; Colleen Kelly, MD
Host Raymond Cross, MD, calls on Dr Colleen Kelly to discuss the increasing prevalence of obesity among patients with IBD, how obesity can complicate Crohn's disease and ulcerative colitis, and the role of GLP-1 RAs and bariatric surgery in...
Host Raymond Cross, MD, calls on Dr Colleen Kelly to discuss the increasing prevalence of obesity among patients with IBD, how obesity can complicate Crohn's disease and ulcerative colitis, and the role of GLP-1 RAs and bariatric surgery in...
Host Raymond Cross, MD, calls on...
04/20/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Jared Magee, MD, on Men's Health in IBD
04/07/2026
Raymond Cross, MD; Jared Magee, MD
Drs Raymond Cross and Jared Magee discuss some of the special concerns that affect men with inflammatory bowel disease, from cardiac concerns to sexual dysfunction and assessing for anal cancer.
Drs Raymond Cross and Jared Magee discuss some of the special concerns that affect men with inflammatory bowel disease, from cardiac concerns to sexual dysfunction and assessing for anal cancer.
Drs Raymond Cross and Jared...
04/07/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: The Best of ECCO 2026
03/25/2026
Raymond Cross, MD; Sara Horst, MD; Jordan Axelrad, MD
Host Raymond Cross, MD, is joined by Drs Sara Horst and Jordan Axelrad to review the findings of their picks for the best presentations from the European Crohn's and Colitis Organization meeting held earlier this year.
Host Raymond Cross, MD, is joined by Drs Sara Horst and Jordan Axelrad to review the findings of their picks for the best presentations from the European Crohn's and Colitis Organization meeting held earlier this year.
Host Raymond Cross, MD, is...
03/25/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Shirley Cohen-Mekelburg, MD on Self-Care for IBD Patients
03/17/2026
Shirley Cohen-Mekelburg; Raymond Cross, MD
Host Raymond Cross, MD, calls on Dr Shirley Mekelburg-Cohen to discuss the importance of self-care among patients with IBD, what self-care consists of, and how to help patients learn to partner with their clinicians in controlling their...
Host Raymond Cross, MD, calls on Dr Shirley Mekelburg-Cohen to discuss the importance of self-care among patients with IBD, what self-care consists of, and how to help patients learn to partner with their clinicians in controlling their...
Host Raymond Cross, MD, calls on...
03/17/2026
Advances in Inflammatory Bowel Disease Network
New IBD Logo
Expert Insights
IBD Drive Time: James Lewis, MD, on Dysplasia Surveillance in IBD
02/23/2026
Raymond Cross, MD; James D. Lewis, MD
Dr James Lewis from the University of Pennsylvania and host Dr Raymond Cross discuss the risk of colon cancer among patients with inflammatory bowel disease, the importance of appropriate surveillance, and special considerations for choosing...
Dr James Lewis from the University of Pennsylvania and host Dr Raymond Cross discuss the risk of colon cancer among patients with inflammatory bowel disease, the importance of appropriate surveillance, and special considerations for choosing...
Dr James Lewis from the...
02/23/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Raymond Cross, MD, on Ostomy Complications
01/13/2026
Raymond Cross, MD; Sara Horst, MD
In this episode of IBD Drive Time, Dr Raymond Cross switches seats and acts as the guest with Sara Horst, MD, as host, to discuss the complexities of ostomy complications.
In this episode of IBD Drive Time, Dr Raymond Cross switches seats and acts as the guest with Sara Horst, MD, as host, to discuss the complexities of ostomy complications.
In this episode of IBD Drive...
01/13/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Conference Coverage
IBD Drive Time: The Best of ACG With Dr Sara Horst
12/01/2025
Raymond Cross, MD; Sara Horst, MD
Dr Sara Horst joins IBD Drive Time host Dr Raymond Cross to review their choices for the best presentations from the American College of Gastroenterology annual meeting.
Dr Sara Horst joins IBD Drive Time host Dr Raymond Cross to review their choices for the best presentations from the American College of Gastroenterology annual meeting.
Dr Sara Horst joins IBD Drive...
12/01/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive Time
Podcast
IBD Drive Time: Freddy Caldera, MD, on Vaccines for Patients With IBD
11/03/2025
Raymond Cross, MD; Freddy Caldera, DO
Freddy Caldera, DO, returns to talk to IBD Drive Time host Raymond Cross, MD, about the best current recommendations for patients with IBD in the midst of controversy and confusion.
Freddy Caldera, DO, returns to talk to IBD Drive Time host Raymond Cross, MD, about the best current recommendations for patients with IBD in the midst of controversy and confusion.
Freddy Caldera, DO, returns to...
11/03/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive Time
Podcast
IBD Drive Time: Megan Riehl, PsyD, on Mental Health and IBD
10/22/2025
Raymond Cross, MD; Megan Riehl, PsyD
Clinical psychologist Megan Riehl, Psy D, talks with IBD Drive Time host Raymond Cross, MD, about the prevalence of anxiety and depression and even post-traumatic stress disorder among patients with inflammatory bowel disease--and how...
Clinical psychologist Megan Riehl, Psy D, talks with IBD Drive Time host Raymond Cross, MD, about the prevalence of anxiety and depression and even post-traumatic stress disorder among patients with inflammatory bowel disease--and how...
Clinical psychologist Megan...
10/22/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive Time
Podcast
IBD Drive Time: Florian Rieder, MD, on Stricturing and Penetrating Crohn's Disease
10/06/2025
Raymond Cross, MD; Florian Rieder
Host Raymond Cross, MD, welcomes back Dr Florian Rieder, an internationally recognized expert in penetrating and stricturing complications of Crohn's disease, to talk about diagnosing, performing endoscopy, and treating this challenging...
Host Raymond Cross, MD, welcomes back Dr Florian Rieder, an internationally recognized expert in penetrating and stricturing complications of Crohn's disease, to talk about diagnosing, performing endoscopy, and treating this challenging...
Host Raymond Cross, MD, welcomes...
10/06/2025
Advances in Inflammatory Bowel Disease Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use